Heberprot-P Has Benefited 300,000 Patients from 26 Nations
More than 300,000 patients from 26 countries have been benefited in the last 10 years with the Heberprot-P, the only product in the world for complex diabetic foot ulcers that shows remarkable results and avoids amputation in most cases.
Diabetic Patients in Mexico Benefit from “Made in Cuba” Medication
Patients in Mexico are already benefiting from Cuba's medication Heberprot-P to treat diabetic foot ulcers.
Las Tunas Stands out in Application of Heberprot-P
More than 362 people from Las Tunas have benefited from Heberprot-P so far this year, a prescribed treatment for diabetic foot ulcer (DFU). This became known during the semiannual evaluation of the Comprehensive Care Program for patients with this condition in the territory and its pre-congress Scientific Day.
Mexico, Cuba Boost Ties with Registration of Heberprot-P
Mexican Minister of Health José Narro praised today the most recent collaboration agreements reached by the two countries, which will bring Cuban biotechnological products to his country, such as Heberprot-P.
Heberprot-P, a Revolutionary Treatment Brings Hope
The Cuban medication Heberprot-P has been used to treat some 290,000 patients, in 20 countries around the world
Heberprot-P, Reaches Slovakia, First Stop in the European Union
Havana, Cuba.- A delegation of Cuban doctors arrived in Slovakia to bring advisory in the application of Heberprot-P, the only drug in the world for the treatment of diabetic foot, reported today CubaMinrex foreign Ministry's website.
Heberprot-P: 10 Years in the Market, 65000 Patients Benefited in Cuba
The medication, developed by a team of researchers at the Center for Genetic Engineering and Biotechnology, was first applied in the province of Sancti Spíritus in June 2007
Cuba Spreads Clinical Trials of Heberprot-P in Russia
Moscow, The clinical trials for the implementation of the Cuban biopharmaceutical drug Heberprot-P in patients with diabetic foot in Russia show today the effectiveness of the medicine, with prospects of being extended to a larger number of regions.
